Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer.

American journal of surgery(2023)

引用 0|浏览11
暂无评分
摘要
In patients with HRPBC treated with NAC and adjuvant radiation, increasing ISET is associated with adverse oncologic outcomes.
更多
查看译文
关键词
Breast cancer,Endocrine therapy,Neoadjuvant chemotherapy,Oncologic outcomes,Radiotherapy,Treatment sequencing
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要